We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EQH:NYSEEquitable Holdings, Inc. Analysis

Data as of 2026-06-16 - not real-time

$45.20

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Equitable Holdings is trading at $45.2, roughly 29% below the DCF‑derived fair value of $50.99, and its forward PE of 5.1 sits well under the industry average of 16.9, suggesting a material valuation discount. The 20‑day SMA ($41.93) and 50‑day SMA ($41.43) are both below the current price, while the 200‑day SMA ($45.09) is just under the market, indicating a tentative upside bias. Technical momentum is supportive – the MACD line is bullish at 0.55 above its signal (0.17) and the RSI at 67 signals strength without being overbought. Volume is trending down, but the stock remains above its key support of $39.42 and near the resistance of $45.44, leaving room for a short‑term breakout. Dividend policy is a bright spot, with a 2.46% yield and a recent announcement of a dividend increase, marking the seventh consecutive raise. However, the fundamentals are strained: trailing EPS is –$2.92, profit margin is –7.3%, and free cash flow is deeply negative, while debt‑to‑equity sits above 300%, raising sustainability questions. The pending Corebridge merger promises scale and potential earnings uplift, but integration risk remains. Overall, the stock offers a compelling valuation upside tempered by earnings volatility and leverage concerns.
The neutral price trend and high 30‑day volatility (≈37%) combine with a beta of 1.28 to flag heightened market sensitivity. Given the mixed signals, a cautious approach is warranted: short‑term buyers may capture the upside if the price breaks resistance, medium‑term investors should monitor merger progress and cash‑flow trends, and long‑term holders need to weigh the valuation gap against the structural earnings challenges.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and RSI indicating momentum
  • Valuation discount of ~29% to DCF fair value
  • Recent dividend increase boosting investor appeal

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Pending Corebridge merger and integration risk
  • Negative earnings and free cash flow constraints
  • Sustained dividend yield but high payout ratio

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant valuation upside if earnings improve
  • High leverage and volatile earnings profile
  • Sector stability in asset management balanced by regulatory exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-7.60%
Profit Margin-7.26%
P/E Ratio5.1
ROE-13.52%
ROA-0.05%
Debt/Equity321.16
P/B Ratio-16.0
Op. Cash Flow$1.1B
Free Cash Flow$-9287000064
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI67.2
Support$39.42
Resistance$45.44
MA 20$41.93
MA 50$41.43
MA 200$45.09
MACDBullish
VolumeDecreasing
Fear & Greed Index92.5

Valuation

Fair Value$50.99
Target Price$58.42
Upside/Downside29.24%
GradeUndervalued
TypeValue
Dividend Yield2.46%

Risk Assessment

Beta1.28
Volatility36.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.